Rankings
▼
Calendar
CYTK FY 2015 Earnings — Cytokinetics, Incorporated Revenue & Financial Results | Market Cap Arena
CYTK
Cytokinetics, Incorporated
$8B
FY 2015 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$29M
-38.9% YoY
Gross Profit
-$18M
-61.9% margin
Operating Income
-$37M
-130.5% margin
Net Income
-$38M
-130.9% margin
EPS (Diluted)
$-0.97
Cash Flow
Operating Cash Flow
$5M
Free Cash Flow
$4M
Stock-Based Comp.
$5M
Balance Sheet
Total Assets
$115M
Total Liabilities
$47M
Stockholders' Equity
$69M
Cash & Equivalents
$65M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$29M
$47M
-38.9%
Gross Profit
-$18M
$3M
-805.6%
Operating Income
-$37M
-$15M
-153.5%
Net Income
-$38M
-$15M
-156.0%
← FY 2014
All Quarters
Q1 2016 →